CRISM Therapeutics Corporation (CRTX) — Financial Flexibility Index
CRISM Therapeutics Corporation (CRTX) has a Financial Flexibility Index of -2.88x as of December 2025. Free cash flow of GBX-1.10 Million (operating CF GBX-1.10 Million minus capex GBX0.00) represents -3% of total liabilities (GBX381.00K). Check CRISM Therapeutics Corporation tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CRISM Therapeutics Corporation Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for CRISM Therapeutics Corporation across 20 annual periods. For the full cash flow conversion analysis, see CRISM Therapeutics Corporation (CRTX) cash flow conversion.
Annual Financial Flexibility Index for CRISM Therapeutics Corporation (2006–2025)
Year-by-year free cash flow to debt coverage for CRISM Therapeutics Corporation. Explore CRISM Therapeutics Corporation cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.08x | GBX-1.94 Million | GBX-1.97 Million | GBX381.00K | ▼ -91.5% |
| 2024 | -2.65x | GBX-905.00K | GBX-933.00K | GBX341.00K | ▲ +11.5% |
| 2023 | -3.00x | GBX-2.76 Million | GBX-2.77 Million | GBX920.19K | ▲ +29.4% |
| 2022 | -4.24x | GBX-3.25 Million | GBX-3.52 Million | GBX765.65K | ▼ -240.0% |
| 2021 | -1.25x | GBX-1.41 Million | GBX-1.83 Million | GBX1.13 Million | ▲ +28.6% |
| 2020 | -1.75x | GBX-1.84 Million | GBX-2.28 Million | GBX1.05 Million | ▲ +1.2% |
| 2019 | -1.77x | GBX-1.51 Million | GBX-1.90 Million | GBX852.24K | ▼ -864.9% |
| 2018 | -0.18x | GBX-507.29K | GBX-2.46 Million | GBX2.76 Million | ▼ -114.9% |
| 2017 | 1.23x | GBX1.16 Million | GBX-2.70 Million | GBX944.00K | ▲ +125.8% |
| 2016 | 0.55x | GBX2.12 Million | GBX-2.01 Million | GBX3.88 Million | ▲ +116.1% |
| 2015 | -3.39x | GBX-2.40 Million | GBX-2.99 Million | GBX709.20K | ▼ -13.7% |
| 2014 | -2.98x | GBX-1.21 Million | GBX-1.96 Million | GBX407.00K | ▲ +85.7% |
| 2013 | -20.81x | GBX-1.55 Million | GBX-1.62 Million | GBX74.25K | ▼ -385.8% |
| 2012 | -4.28x | GBX-313.65K | GBX-750.98K | GBX73.21K | ▲ +70.0% |
| 2011 | -14.26x | GBX-1.45 Million | GBX-2.67 Million | GBX102.00K | ▼ -240.2% |
| 2010 | -4.19x | GBX-459.55K | GBX-778.08K | GBX109.60K | ▼ -135.7% |
| 2009 | -1.78x | GBX-514.97K | GBX-843.95K | GBX289.43K | ▼ -141.1% |
| 2008 | 4.33x | GBX1.27 Million | GBX-2.06 Million | GBX292.12K | ▼ -61.1% |
| 2007 | 11.13x | GBX1.95 Million | GBX-692.47K | GBX175.32K | ▼ -46.2% |
| 2006 | 20.67x | GBX324.68K | GBX-998.08K | GBX15.71K | — |